Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Omkar Pravin Herlekar | Chairman & MD | -- | -- | 1981 |
| Ms. Mitti Jain C.S. | Company Secretary & Compliance Officer | -- | -- | -- |
| Mr. Umesh Shankar Pawar | Additional Executive Director | -- | -- | 1984 |
| Ms. Varsha Pravin Joshi | Chief Financial Officer | -- | -- | -- |
| Mr. Anil Fargade | Senior Accounts Officer | -- | -- | -- |
| Mr. Sunil Sitale | Manager of HR & Admin | -- | -- | -- |
Lasa Supergenerics Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 77
Description
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Corporate Governance
Upcoming Events
May 28, 2025 at 10:59 AM UTC - June 2, 2025 at 12:00 PM UTC
Lasa Supergenerics Limited Earnings Date
Recent Events
September 16, 2022 at 12:00 AM UTC
Ex-Dividend Date